share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Bhatt Deepak

SEC announcement ·  Apr 3 06:41
Summary by Futu AI
In a recent transaction, Bhatt Deepak, associated with Bristol-Myers Squibb (BMY), was reported to have engaged in a market action on March 31, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting ownership stake, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
In a recent transaction, Bhatt Deepak, associated with Bristol-Myers Squibb (BMY), was reported to have engaged in a market action on March 31, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting ownership stake, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.